Novartis: Streamlining analytics & AI across the organization

Novartis Pharmaceuticals leveraged Dataiku's powerful platform to tackle critical business challenges in the fast-paced pharmaceutical industry, achieving significant efficiency gains and fostering a culture of innovation. By adopting Dataiku's LLM Mesh and GenAI builder capabilities, Novartis drastically reduced the time needed to develop GenAI chatbots, which enhanced their ability to conduct healthcare market research by streamlining the analysis of extensive data, such as interview transcripts. The integration of Dataiku enabled a 90% reduction in time to insights for their GenAI use case and a 600% acceleration in data ingestion time for spreadsheet tasks, transforming manual, time-consuming processes into automated, real-time analyses. This advancement not only democratized data access and improved decision-making agility but also empowered data practitioners and citizen data scientists across the organization. With automated ML model solutions, real-time data refreshes, and intuitive dashboards, Novartis improved its operational performance, reduced costs, and increased its confidence in data-driven decisions, aligning with its vision to advance in an AI- and data-driven future.

No tracked trend matches for this post yet.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.